Tracon Pharmaceuticals, Inc.
TCONDelisted Jul 19, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001394319
Tracon Pharmaceuticals, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Mar 13, 2024; 29 institutions reported holding it in 13F filings for Q1 2024, worth $1.39M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Tracon Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 44 | 2 | 45 | +3 |
| Shares | 9.02M | 127.7K | 10.2M | +1.34M (+15.1%) |
| Value | $58.5M | $829.0K | $39.6M | −$18.1M (−31.4%) |
2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Tracon Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Altium Capital Management LP | 785,341 | $3.04M | 0.81% |
| Psagot Investment House Ltd. | 143,591 | $556.0K | 0.10% |
| Psagot Value Holdings Ltd. / (Israel) | 143,591 | $556.0K | 0.10% |
| Millennium Management LLC | 139,477 | $540.0K | 0.00% |
| Johnson & Johnson | 84,003 | $325.0K | 0.03% |
| Franklin Resources Inc | 43,700 | $169.0K | 0.00% |
| Virtu Financial LLC | 14,938 | $58.0K | 0.01% |
| Goldman Sachs Group Inc | 10,755 | $42.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 445 | $2.00K | 0.00% |
Sold out (6)
Institutions that held Tracon Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Marshall Wace, LLP | 56,351 | $366.0K |
| Susquehanna Fundamental Investments, LLC | 31,616 | $205.0K |
| Price T Rowe Associates Inc | 17,400 | $113.0K |
| Vigilare Wealth Management | 17,000 | $110.0K |
| Advisory Services Network, LLC | 1,000 | $6.00K |
| Group One Trading, L.P. | 800 | $5.00K |
Not filed for Q3 2021 yet (2)
Institutions that held Tracon Pharmaceuticals, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 84,003 | $545.0K |
| QS Investors, LLC | 43,700 | $284.0K |